Time in Range (TIR), a new statistic introduced by CGM systems. It measures how long a person's blood glucose levels remain within a particular range. According to Professor Kar, TIR provides "a ...

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...

This innovative approach aims to assess the association between CGM-derived time-in-range (TIR) metrics and the risk of microvascular complications in individuals with Type 1 diabetes (T1D ...

Time in range was similar among pediatric patients with type 1 diabetes who used either the Insulet Omnipod 5 or the Tandem Control IQ.

However, the use of continuous glucose monitoring is on the rise and ... These readings included the time spent in "tight range" (between 70 and 140 mg/DL) as well as the time spent above 140 ...

China: A new study published in Diabetes, Obesity and Metabolism has highlighted the significant role of tight glycemic ...

The introduction of the continuous glucose monitor (CGM) made that unnecessary ... and sounds an alarm when they move out of a normal range. Blood sugar that's too high could call for a dose ...